Browsing by Author Cantilena, S
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
---|---|---|
2012 | A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma | Sottile, F; Gnemmi, I; Cantilena, S; D'Acunto, WC; Sala, A |
2011 | Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas | Cantilena, S; Pastorino, F; Pezzolo, A; Chayka, O; Pistoia, V; Ponzoni, M; Sala, A |
2013 | Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications | Corvetta, D; Chayka, O; Gherardi, S; D'Acunto, CW; Cantilena, S; Valli, E; Piotrowska, I; Perini, G; Sala, A |
2013 | Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells | Santilli, G; Piotrowska, I; Cantilena, S; Chayka, O; D'Alicarnasso, M; Morgenstern, DA; Himoudi, N; Pearson, K; Anderson, J; Thrasher, AJ; Sala, A |
2016 | A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma | Dvorkina, M; Nieddu, V; Chakelam, S; Pezzolo, A; Cantilena, S; Leite, AP; Chayka, O; Regad, T; Pistorio, A; Sementa, AR; Virasami, A; Barton, J; Montano, X; Lechertier, T; Brindle, N; Morgenstern, D; LE Bras, M; Burns, A; Saunders, N; Hodivala-Dilke, K; Bagella, L; de The, H; Anderson, J; Sebire, N; Pistoia, V; Sala, A; Salomoni, P |